Prostate MRI: Diffusion-weighted imaging at 1.5T correlates better with prostatectomy Gleason grades than TRUS-guided biopsies in peripheral zone tumours

European Radiology

Volumn 22, Issue 2, 2012, Pages 468-475

  Bittencourt, Leonardo Kayat ^a   Barentsz, Jelle O ^b   De Miranda, Luiz Carlos Duarte ^a   Gasparetto, Emerson Leandro ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

biological markers; Biopsy; Diffusion magnetic resonance imaging; Magnetic resonance imaging; Prostate cancer

Indexed keywords

ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CLINICAL ARTICLE; CLINICAL TRIAL; DIAGNOSTIC ACCURACY; DIFFUSION COEFFICIENT; DIFFUSION WEIGHTED IMAGING; GLEASON SCORE; HUMAN; INTERMETHOD COMPARISON; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY; TRANSRECTAL ULTRASONOGRAPHY;

AGED; AREA UNDER CURVE; BIOPSY; DIFFUSION MAGNETIC RESONANCE IMAGING; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; REPRODUCIBILITY OF RESULTS; ROC CURVE; ULTRASONOGRAPHY; ULTRASOUND, HIGH-INTENSITY FOCUSED, TRANSRECTAL;

EID: 84856622890     PISSN: 09387994     EISSN: 14321084     Source Type: Journal    
DOI: 10.1007/s00330-011-2269-1     Document Type: Article

References (44)

1. Society AC (2009) Cancer facts and figures 2009. Available at http://www.cancer.org/Research/CancerFactsFigures/cancer-facts-figures-2009. Accessed September 1, 2011
2. A Bill-Axelson L Holmberg M Ruutu, et al. 2005 Radical prostatectomy versus watchful waiting in early prostate cancer N Engl J Med 352 1977 15888698 10.1056/NEJMoa043739 1:CAS:528:DC%2BD2MXjvFyrtLw%3D (Pubitemid 40638368)
3. AV D'Amico R Whittington SB Malkowicz, et al. 1998 Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer Jama 280 969 9749478 10.1001/jama.280.11.969 (Pubitemid 28445094)
4. AW Partin LA Mangold DM Lamm PC Walsh JI Epstein JD Pearson 2001 Contemporary update of prostate cancer staging nomograms (Partin Tables) for the new millennium Urology 58 843 848 11744442 10.1016/S0090-4295(01)01441-8 1:STN:280:DC%2BD3MnpvV2htg%3D%3D (Pubitemid 34017254)
5. AV D'Amico J Moul PR Carroll L Sun D Lubeck MH Chen 2003 Cancer-specific mortality after surgery or radiation for patients with clinically localized prostate cancer managed during the prostate-specific antigen era J Clin Oncol 21 2163 12775742 10.1200/JCO.2003.01.075 (Pubitemid 46606365)
6. AJ Stephenson PT Scardino JA Eastham, et al. 2005 Postoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy J Clin Oncol 23 7005 16192588 10.1200/JCO.2005.01.867
7. Gleason DF, Mellinger GT (1974) the Veterans administration cooperative urological research group: prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging(ed)^(eds), pp 58-64
8. J Epstein W Allsbrook Jr M Amin L Egevad 2005 The 2005 International Society of Urological Pathology (ISUP) consensus conference on Gleason grading of prostatic carcinoma Am J Surg Pathol 29 1228 16096414 10.1097/01.pas. 0000173646.99337.b1 (Pubitemid 41232997)
9. M Blute E Bergstralh A Iocca B Scherer H Zincke 2001 Use of Gleason score, prostate specific antigen, seminal vesicle and margin status to predict biochemical failure after radical prostatectomy J Urol 165 119 11125379 10.1097/00005392-200101000-00030 1:STN:280:DC%2BD3M%2FovFWmtg%3D%3D
10. L Egevad T Granfors L Karlberg A Bergh P Stattin 2002 Percent Gleason grade 4/5 as prognostic factor in prostate cancer diagnosed at transurethral resection J Urol 168 509 513 12131299 10.1016/S0022-5347(05)64669-1 (Pubitemid 34793283)
11. M Cohen R Hanley T Kurteva, et al. 2008 Comparing the Gleason prostate biopsy and Gleason prostatectomy grading system: the Lahey Clinic Medical Center experience and an international meta-analysis Eur Urol 54 371 381 18395322 10.1016/j.eururo.2008.03.049
12. R Kvåle B Møller R Wahlqvist, et al. 2009 Concordance between Gleason scores of needle biopsies and radical prostatectomy specimens: a population-based study BJU Int 103 1647 1654 19154461 10.1111/j.1464-410X.2008. 08255.x
13. A Rajinikanth M Manoharan CT Soloway FJ Civantos MS Soloway 2008 Trends in Gleason score: concordance between biopsy and prostatectomy over 15 years Urology 72 177 182 18279938 10.1016/j.urology.2007.10.022
14. Stav K, Merald H, Leibovici D, Lindner A, Zisman A (2007) Does prostate biopsy Gleason score accurately express the biologic features of prostate cancer?(ed)^(eds). Elsevier, pp 383-386 (Pubitemid 47362756)
15. JJ Neil 1997 Measurement of water motion (apparent diffusion) in biological systems Concepts Magn Reson 9 385 401 10.1002/(SICI)1099-0534(1997)9: 6<385::AID-CMR2>3.0.CO;2-V 1:CAS:528:DyaK2sXmvVyltbs%3D (Pubitemid 127135317)
16. E Pagani A Bizzi F Di Salle N De Stefano M Filippi 2008 Basic concepts of advanced MRI techniques Neurol Sci 29 290 295 18941716 10.1007/s10072-008-1001- 7
17. A Qayyum 2009 Diffusion-weighted imaging in the abdomen and pelvis: concepts and applications Radiographics 29 1797 1810 19959522 10.1148/rg.296095521
18. Y Guo YQ Cai ZL Cai, et al. 2002 Differentiation of clinically benign and malignant breast lesions using diffusion weighted imaging J Magn Reson Imaging 16 2 172 178 12203765 10.1002/jmri.10140 (Pubitemid 34810055)
19. FPA Pereira G Martins E Figueiredo, et al. 2009 Assessment of breast lesions with diffusion-weighted MRI: comparing the use of different b values Am J Roentgenol 193 1030 10.2214/AJR.09.2522
20. T Sugahara Y Korogi M Kochi, et al. 1999 Usefulness of diffusion-weighted MRI with echo-planar technique in the evaluation of cellularity in gliomas J Magn Reson Imaging 9 53 60 10030650 10.1002/(SICI)1522-2586(199901)9:1<53:: AID-JMRI7>3.0.CO;2-2 1:STN:280:DyaK1M7ltlOhsw%3D%3D (Pubitemid 29068231)
21. NM de Souza SA Reinsberg ED Scurr JM Brewster GS Payne 2007 Magnetic resonance imaging in prostate cancer: the value of apparent diffusion coefficients for identifying malignant nodules Br J Radiol 80 90 95 10.1259/bjr/24232319 10.1259/bjr/24232319 (Pubitemid 46951251)
22. K Hosseinzadeh SD Schwarz 2004 Endorectal diffusion weighted imaging in prostate cancer to differentiate malignant and benign peripheral zone tissue J Magn Reson Imaging 20 654 661 15390142 10.1002/jmri.20159 (Pubitemid 39313742)
23. B Issa 2002 In vivo measurement of the apparent diffusion coefficient in normal and malignant prostatic tissues using echo planar imaging J Magn Reson Imaging 16 196 200 12203768 10.1002/jmri.10139 (Pubitemid 34810058)
24. MD Pickles P Gibbs M Sreenivas LW Turnbull 2006 Diffusion weighted imaging of normal and malignant prostate tissue at 3.0T J Magn Reson Imaging 23 130 134 16374882 10.1002/jmri.20477 (Pubitemid 43191065)
25. C Sato S Naganawa T Nakamura, et al. 2005 Differentiation of noncancerous tissue and cancer lesions by apparent diffusion coefficient values in transition and peripheral zones of the prostate J Magn Reson Imaging 21 258 262 15723379 10.1002/jmri.20251 (Pubitemid 40280120)
26. A Tanimoto J Nakashima H Kohno H Shinmoto S Kuribayashi 2007 Prostate cancer screening: the clinical value of diffusion weighted imaging and dynamic MR imaging in combination with T2 weighted imaging J Magn Reson Imaging 25 146 152 17139633 10.1002/jmri.20793 (Pubitemid 46095209)
27. J Xu PA Humphrey AS Kibel, et al. 2009 Magnetic resonance diffusion characteristics of histologically defined prostate cancer in humans Magn Reson Med 61 842 850 19215051 10.1002/mrm.21896
28. AR Padhani G Liu D Mu-Koh, et al. 2009 Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations Neoplasia (New York, NY) 11 102 1:CAS:528:DC%2BD1MXhvVOls70%3D
29. N DeSouza S Riches N Vanas, et al. 2008 Diffusion-weighted magnetic resonance imaging: a potential non-invasive marker of tumour aggressiveness in localized prostate cancer Clin Radiol 63 774 782 18555035 10.1016/j.crad.2008. 02.001 1:STN:280:DC%2BD1czos1Ohsg%3D%3D
30. Y Itou K Nakanishi Y Narumi Y Nishizawa H Tsukuma 2011 Clinical utility of apparent diffusion coefficient (ADC) values in patients with prostate cancer: can ADC values contribute to assess the aggressiveness of prostate cancer? J Magn Reson Imaging 33 167 172 21182135 10.1002/jmri.22317
31. T Tamada T Sone Y Jo, et al. 2008 Apparent diffusion coefficient values in peripheral and transition zones of the prostate: comparison between normal and malignant prostatic tissues and correlation with histologic grade J Magn Reson Imaging 28 720 726 18777532 10.1002/jmri.21503
32. B Turkbey VP Shah Y Pang, et al. 2011 Is apparent diffusion coefficient associated with clinical risk scores for prostate cancers that are visible on 3-T MR images? Radiology 258 488 495 21177390 10.1148/radiol.10100667
33. S Verma A Rajesh H Morales, et al. 2011 Assessment of aggressiveness of prostate cancer: correlation of apparent diffusion coefficient with histologic grade after radical prostatectomy Am J Roentgenol 196 374 10.2214/AJR.10.4441
34. CA Woodfield GA Tung DJ Grand JA Pezzullo JT Machan JF Renzulli 2010 Diffusion-weighted MRI of peripheral zone prostate cancer: comparison of tumor apparent diffusion coefficient with Gleason score and percentage of tumor on core biopsy Am J Roentgenol 194 W316 10.2214/AJR.09.2651
35. JI Epstein J Srigley D Grignon P Humphrey 2007 Recommendations for the reporting of prostate carcinoma Hum Pathol 38 1305 1309 17707261 10.1016/j.humpath.2007.05.015 (Pubitemid 47247492)
36. A Graser A Heuck B Sommer, et al. 2007 Per-sextant localization and staging of prostate cancer: correlation of imaging findings with whole-mount step section histopathology Am J Roentgenol 188 84 10.2214/AJR.06.0401 (Pubitemid 46012493)
37. TL Chenevert PC Sundgren BD Ross 2006 Diffusion imaging: insight to cell status and cytoarchitecture Neuroimaging Clin N Am 16 619 17148023 10.1016/j.nic.2006.06.005 (Pubitemid 44828754)
38. I San Francisco W DeWOLF S Rosen M Upton A Olumi 2003 Extended prostate needle biopsy improves concordance of Gleason grading between prostate needle biopsy and radical prostatectomy J Urol 169 136 140 12478121 10.1016/S0022-5347(05)64053-0 (Pubitemid 35461571)
39. JJA Smith PT Scardino MI Resnick AD Hernandez SC Rose MJ Egger 1997 Transrectal ultrasound versus digital rectal examination for the staging of carcinoma of the prostate: results of a prospective, multi-institutional trial J Urol 157 902 906 10.1016/s0022-5347(01)65079-1 9072596 10.1016/S0022-5347(01) 65079-1 (Pubitemid 27066276)
40. M Norberg L Egevad L Holmberg P Sparén BJ Norlén C Busch 1997 The sextant protocol for ultrasound-guided core biopsies of the prostate underestimates the presence of cancer Urology 50 562 566 10.1016/s0090-4295(97) 00306-3 9338732 10.1016/S0090-4295(97)00306-3 1:STN:280:DyaK2svnvVCrsw%3D%3D (Pubitemid 27433216)
41. S Xu J Kruecker B Turkbey, et al. 2008 Real-time MRI-TRUS fusion for guidance of targeted prostate biopsies Comput Aided Surg 13 255 264 18821344 10.3109/10929080802364645
42. T Hambrock JJ Futterer HJ Huisman, et al. 2008 Thirty-two-channel coil 3T magnetic resonance-guided biopsies of prostate tumor suspicious regions identified on multimodality 3T magnetic resonance imaging: technique and feasibility Invest Radiol 43 686 694 18791410 10.1097/RLI.0b013e31817d0506
43. T Hambrock DM Somford C Hoeks, et al. 2010 Magnetic resonance imaging guided prostate biopsy in men with repeat negative biopsies and increased prostate specific antigen J Urol 183 2 520 527 10.1016/j.juro.2009.10.022 20006859 10.1016/j.juro.2009.10.022 1:CAS:528:DC%2BC3cXitVSrt7c%3D
44. L Wang H Hricak MW Kattan, et al. 2007 Prediction of seminal vesicle invasion in prostate cancer: incremental value of adding endorectal mr imaging to the kattan nomogram1 Radiology 242 182 188 17090712 10.1148/radiol.2421051254 (Pubitemid 44956023)